Erratum: Cardiovascular risks associated with low dose ionizing particle radiation (PLoS ONE (2014) 9:10 (e110269) 10.1371/journal.pone.0110269);Cardiovascular risks associated with low dose ionizing particle radiation

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Yan, Xinhua ^a,c   Sasi, Sharath P ^a   Gee, Hannah ^a   Lee, JuYong ^a,b   Yang, Yongyao ^a   Mehrzad, Raman ^d   Onufrak, Jillian ^a   Song, Jin ^a   Enderling, Heiko ^e   Agarwal, Akhil ^a   Rahimi, Layla ^a   Morgan, James ^c,d   Wilson, Paul F ^f   Carrozza, Joseph ^a,c,g   Walsh, Kenneth ^h   Kishore, Raj ⁱ   Goukassian, David A ^a,c,h  

^a Cardiovascular Research Center GeneSys Research Institute   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Carney Hospital   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f BROOKHAVEN NATIONAL LABORATORY   (United States)

^g ST ELIZABETH'S MEDICAL CENTER   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; IONIZING RADIATION; IRON ION IRRADIATION; MALE; MOUSE; NONHUMAN; PROTON RADIATION; RADIATION DOSE; RISK ASSESSMENT; SURVIVAL; ACUTE DISEASE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; COSMONAUT; DISEASE MODEL; HEART; HEART FUNCTION TEST; HUMAN; METABOLISM; PATHOPHYSIOLOGY; RADIATION RESPONSE; RISK; SPACE FLIGHT; TIME FACTOR; WHOLE BODY RADIATION;

IRON; PROTON;

ACUTE DISEASE; ANIMALS; ASTRONAUTS; DISEASE MODELS, ANIMAL; HEART; HEART FUNCTION TESTS; HUMANS; IRON RADIOISOTOPES; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL ISCHEMIA; PROTONS; RADIATION DOSAGE; RADIATION, IONIZING; RISK; SPACE FLIGHT; TIME FACTORS; WHOLE-BODY IRRADIATION;

EID: 84908280970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142764     Document Type: Erratum

References (38)

1. Gyenes G, Fornander T, Carlens P, Rutqvist LE (1994) Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy. International journal of radiation oncology, biology, physics 28: 1235-1241.
2. Taylor CW, McGale P, Darby SC (2006) Cardiac risks of breast-cancer radiotherapy: a contemporary view. Clinical oncology (Royal College of Radiologists (Great Britain)) 18: 236-246.
3. Gayed IW, Liu HH, Yusuf SW, Komaki R, Wei X, et al. (2006) The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. J Nucl Med 47: 1756-1762.
4. Emerit I, Levy A, Cernjavski L, Arutyunyan R, Oganesyan N, et al. (1994) Transferable clastogenic activity in plasma from persons exposed as salvage personnel of the Chernobyl reactor. Journal of cancer research and clinical oncology 120: 558-561.
5. Bose AS, Shetty V, Sadiq A, Shani J, Jacobowitz I (2009) Radiation induced cardiac valve disease in a man from Chernobyl. J Am Soc Echocardiogr 22: 973 e971-973.
6. Pant GS, Kamada N (1977) Chromosome aberrations in normal leukocytes induced by the plasma of exposed individuals. Hiroshima journal of medical sciences 26: 149-154.
7. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, et al. (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. The New England journal of medicine 368: 987-998.
8. Convertino VA (2009) Status of cardiovascular issues related to space flight: Implications for future research directions. Respiratory physiology & neurobiology 169 Suppl 1: S34-37.
9. Hoffman SJ, Kaplan DI (1997) Human Exploration of Mars: The Reference Mission of the NASA Mars Exploration Study Team. National Aeronautics and Space Administration (NASA).
10. Zeitlin C, Hassler DM, Cucinotta FA, Ehresmann B, Wimmer-Schweingruber RF, et al. (2013) Measurements of energetic particle radiation in transit to Mars on the Mars Science Laboratory. Science (New York, NY 340: 1080-1084.
11. Reitz G (2008) Characteristic of the radiation field in low Earth orbit and in deep space. Z Med Phys 18: 233-243.
12. Mewaldt RA (1994) Galactic cosmic ray composition and energy spectra. Adv Space Res 14: 737-747.
13. D'Agostino RB Sr., Grundy S, Sullivan LM, Wilson P, Group CHDRP (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286: 180-187.
14. NASA (1998) Strategic Program Plan for Space Radiation Health Research. Life Sciences Division, Office of Life and Microgravity Sciences and Applications.
15. Jermann M (2014) Particle Therapy Statistics in 2013. International Journal of Particle Therapy 1: 40-43.
16. Zolotareva AG, Kogan ME (1978) Production of experimental occlusive myocardial infarction in mice. Cor et vasa 20: 308-314.
17. Patten RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, et al. (1998) Ventricular remodeling in a mouse model of myocardial infarction. The American journal of physiology 274: H1812-1820.
18. Ding B, Price RL, Goldsmith EC, Borg TK, Yan X, et al. (2000) Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. Circulation 101: 2854-2862.
19. Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, et al. (2007) Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol 102: 2104-2111.
20. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA doublestranded breaks induce histone H2AX phosphorylation on serine 139. The Journal of biological chemistry 273: 5858-5868.
21. Mungrue IN, Gros R, You X, Pirani A, Azad A, et al. (2002) Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. The Journal of clinical investigation 109: 735-743.
22. Shigekawa M, Iwamoto T (2001) Cardiac Na(+)-Ca(2+) exchange: molecular and pharmacological aspects. Circulation research 88: 864-876.
23. Yang TT, Xiong Q, Enslen H, Davis RJ, Chow CW (2002) Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Molecular and cellular biology 22: 3892-3904.
24. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
25. Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, et al. (2009) Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 120: S247-254.
26. Vilahur G, Juan-Babot O, Pena E, Onate B, Casani L, et al. (2011) Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. Journal of molecular and cellular cardiology 50: 522-533.
27. Tenhunen O, Soini Y, Ilves M, Rysa J, Tuukkanen J, et al. (2006) p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms. FASEB J 20: 1907-1909.
28. Lemke LE, Bloem LJ, Fouts R, Esterman M, Sandusky G, et al. (2001) Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart. Journal of molecular and cellular cardiology 33: 1527-1540.
29. Schillinger W, Fiolet JW, Schlotthauer K, Hasenfuss G (2003) Relevance of Na+-Ca2+ exchange in heart failure. Cardiovascular research 57: 921-933.
30. Kass DA, Bronzwaer JG, Paulus WJ (2004) What mechanisms underlie diastolic dysfunction in heart failure? Circulation research 94: 1533-1542.
31. Hasenfuss G, Schillinger W, Lehnart SE, Preuss M, Pieske B, et al. (1999) Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99: 641-648.
32. Li C, Li J, Cai X, Sun H, Jiao J, et al. (2011) Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors. The Journal of biological chemistry 286: 40782-40791.
33. Bushdid PB, Osinska H, Waclaw RR, Molkentin JD, Yutzey KE (2003) NFATc3 and NFATc4 are required for cardiac development and mitochondrial function. Circulation research 92: 1305-1313.
34. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, et al. (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228.
35. Marber MS, Rose B, Wang Y (2011) The p38 mitogen-activated protein kinase pathway-a potential target for intervention in infarction, hypertrophy, and heart failure. Journal of molecular and cellular cardiology 51: 485-490.
36. Sun Y (2009) Myocardial repair/remodelling following infarction: roles of local factors. Cardiovascular research 81: 482-490.
37. Vilahur G, Casani L, Pena E, Duran X, Juan-Babot O, et al. (2009) Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction. Atherosclerosis 206: 95-101.
38. Shorofsky SR, Aggarwal R, Corretti M, Baffa JM, Strum JM, et al. (1999) Cellular mechanisms of altered contractility in the hypertrophied heart: big hearts, big sparks. Circulation research 84: 424-434.